Immunopathogenesis of Chlamydia

Completed

Conditions studied: CHLAMYDIA INFECTIONS

In brief

Sexually transmitted Chlamydia trachomatis infections are a widespread public health concern due to their prevalence and potentially devastating reproductive consequences, including pelvic inflammatory disease, infertility, and ectopic pregnancy. The goal of this study is to evaluate the risk factors for adverse outcomes following genital tract infection with Chlamydia trachomatis and to evaluate whether or not the presence of C. trachomatis in the rectum act as a reservoir for infection.

Key facts

Study ID

NCT00607659

Run by

Arkansas Children's Hospital Research Institute

People needed

29

Starts

2008-01-01

Expected to finish

2016-01-01

Last updated by the study team

2016-04-14

Who can join

Age: 11 and older, up to 21. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Female
• 11 to 21 years of age at the time of enrollment
• Positive for Chlamydia infections by urine or cervical PCR
• 5th Chlamydia-negative subject who fits all other inclusion criteria
• Negative pregnancy test
• Written informed consent provided
• Signed a HIPAA authorization form
• Willingness to comply with all the requirements of the protocol

You may not qualify if…

• Positive pregnancy test
• Negative for Chlamydia, unless 5th negative subject to be in the control group
• Any condition that in the opinion of the investigator would interfere with the ability of the potential subject to complete the study or would result in significant risk to the subject

Where it is running

• Arkansas Children's Hospital — Little Rock, Arkansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.